tiprankstipranks
Imagin Medical Inc (TSE:IME)
CNQX:IME
Holding TSE:IME?
Track your performance easily

Imagin Medical (IME) Income Statement

6 Followers

Imagin Medical Income Statement

Last quarter (Q3 2023), Imagin Medical's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Imagin Medical's net income was C$4.79M. See Imagin Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 2.32MC$ 3.55MC$ 3.87MC$ 4.38MC$ 4.55MC$ 7.95M
Operating Income
C$ -2.32MC$ -3.55MC$ -3.87MC$ -4.38MC$ -4.55MC$ -7.95M
Net Non Operating Interest Income Expense
C$ -11.51KC$ -7.83KC$ 6.93KC$ -5.53KC$ -62.69KC$ -10.06K
Other Income Expense
C$ -500.44KC$ -1.04MC$ -7.59MC$ -4.26KC$ 25.58KC$ -15.93K
Pretax Income
C$ -734.33KC$ -2.49MC$ -11.47MC$ -4.38MC$ -4.46MC$ -7.96M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -734.33KC$ -2.49MC$ -11.47MC$ -4.38MC$ -4.46MC$ -7.96M
Basic EPS
C$ -0.06C$ -0.25C$ -1.27C$ -10.60C$ -12.00C$ -28.00
Diluted EPS
C$ -0.07C$ -0.25C$ -1.27C$ -10.60C$ -12.00C$ -28.00
Basic Average Shares
C$ 42.04MC$ 10.00MC$ 9.05MC$ 414.85KC$ 347.36KC$ 268.45K
Diluted Average Shares
C$ 42.04MC$ 10.00MC$ 9.05MC$ 414.85KC$ 347.36KC$ 268.45K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 2.32MC$ 3.55M----
Net Income From Continuing And Discontinued Operation
C$ -734.33KC$ -2.49MC$ -11.47MC$ -4.38MC$ -4.46MC$ -7.96M
Normalized Income
C$ -1.08MC$ -1.83MC$ -877.89KC$ -3.22MC$ -3.28MC$ -5.85M
Interest Expense
------
EBIT
C$ -726.20KC$ -2.48MC$ -11.47MC$ -4.37MC$ -4.45MC$ -7.95M
EBITDA
C$ -563.03KC$ -2.44MC$ -11.44MC$ -4.34MC$ -4.43MC$ -7.93M
Currency in CAD

Imagin Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis